 Monday, September 4, 2:00 - 3:00 p.m. K.E.L. McCOLL (UK) - R.H. HUNT(Canada) Where is the GEJ, Where is the LES, Where is the SCJ,and Where is the Acid Pocket?  Where is the gastro-esophageal pH step-up under fasting conditions and following a meal? J.E.Pandolfino (Chicago) Where, and what, are the three components of the distal esophageal HPZ? L. Miller (Philadelphia) Where is the SCJ and what is cardia mucosa in healthy controls and in patients with reflux esophagitis? S.J.Spechler (Dallas) Where, and what, is the unbuffered acid pocket in healthy controls and in patients with reflux esophagitis? A. Clarke (Glasgow)    Monday, September 4, 3:15 - 4:15 p.m. H.W. BOYCE (USA) - I.F. HERRMANN (Italy) The Lausanne experience with treatment for benign esophageal stenosis using the Savary technique Ph. Monnier (Lausanne) A gastroenterologist’s approach for dilating benign esophageal strictures R. K.H. Wong (Washington) Bougienage versus surgery as treatment of stenosis of pharynx and upper esophagus H. Mahieu (Amsterdam) Endoscopic lumen restoration for total pharyngo-esophageal obstruction Worth Boyce (Tampa) 
Monday, September 4, 4:30 - 5:30 p.m.
J.P. GALMICHE (France)- R.C. ORLANDO (USA) Towards the Mechanisms of Heartburn in Acid and Non-Acid GERD Pathological and Non-Pathological Acid Reflux Mechanisms of Failed Medical Therapy for GERD Mechanisms of heartburn in erosive and non-erosive reflux disease R.C. Orlando (New Orleans) The case for non-acid reflux in the pathogenesis of reflux-induced signs and symptoms N. Johnston (Milwaukee) Role of sustained esophageal contractions in the pathogenesis of heartburn and chest pain R.K. Mittal (San Diego) Mechanisms for failure of proton pump inhibitor therapy in patients presumed to have symptomatic non-erosive reflux disease J.P. Galmiche (Nantes)  Tuesday, September 5, 2:00 - 3:00 p.m. H. INOUE (Japan) - W.M. WEINSTEIN (USA) Emerging techniques in the diagnosis of diseases of the foregut. Advanced imaging technology using wireless capsule endoscopy J.P. Durand (Paris). Detection of high grade dysplasia on Barrett esophagus using NBI imaging system G.W. Falk (Cleveland) Cellular level imaging using Optiscan W.M. Weinstein (Los Angeles) In vivo observation of living cancer cell using Endocytoscopy H. Inoue (Yokohama)  Tuesday, September 5, 3:15 - 4:15 p.m. H.S. GAREWAL (Tucson) Acid and bile acid-induced inflammation: it's role in Barrett's esophagus N. Buttar (Rochester, MN) Induction of Barrett's metaplasia by acid and bile acid R. Fitzgerald (Cambridge) Synergetic effects of low pH and bile acids K. Dvorakova (Tucson) Summary and overview G. Triadafilopoulos (Stanford)  Tuesday, September 5, 4:30 - 5:30 p.m. A.H. HÖLSCHER (Germany) - R.E. SAMPLINER (USA) Surgical and non-Surgical Management of Barrett's Cancer Endoscopic mucosectomy is the treatment of choice for mucosal Barrett's carcinoma Combination therapy in Barrett cancer R.E. Sampliner (Tucson) Merendino operation is the treatment of choice for mucosal Barrett's cancer J. Salo (Helsinki) High rate of lymph node metastasis in submucosal Barrett's cancer - consequence of choice of therapy A.H. Hölscher (Cologne)  Wednesday, September 6, 2:00 - 3:00 p.m. H.D. APPELMAN (USA) - G.CHEJFEC(USA) Controversies from the Pathologist Is squamous cell carcinoma of esophagus, arising in a background of Barrett mucosa, a form of Barrett?s carcinoma? K.Takubo (Tokyo) What are the uses of genetic and molecular markers of Barrett mucosa in routine diagnostic pathology practice? R.H. Riddell (Toronto) What are the minimal criteria for the diagnosis of low grade dysplasia in Barrett’s mucosa? E. Montgomery (Baltimore) What are the minimal criteria for the diagnosis of high grade dysplasia in Barrett’s mucosa? H.D. Appelman (Ann Arbor) What is the reproducibility of diagnosis of Barrett metaplasia / dysplasia in images submitted to a panel of pathologists? G. Chejfec (Chicago) Can resection margins be adequately determined in endoscopic mucosal resections of Barett’s dysplasias and carcinomas? J. Hart (Chicago)  Wednesday, September 6, 3:15 - 4:15 p.m. B.D. SCHIRMER (USA) - F. de la CRUZ VIGO (Spain) Effects of Surgery for Morbid Obesity on the Foregut Esophageal motility disorders after laparoscopic adjustable banding B.K. Oeschlager (Seattle) Motility disorders after gastric bypass B. Schirmer (Kansas City) The effects of bariatric operations on GERD J. Ortega (Valencia) Marginal ulcers after bariatric surgery V. de la Cruz (Madrid)  Wednesday, September 6, 4:30 - 5:30 p.m. C.A. PELLEGRINI (USA) - J.E. RICHTER(USA) Surgery for motor Disorders of the Esophagus Medical treatment and comparison of dilatation and Heller operation L. Bonavina (Milan) Role of esophageal function tests (including impedance) in the Pre and Postoperative (or post-dilation) state for achalasia patients B.K. Oelschlager (Seattle) Operative treatment of achalasia H.J. Stein (Salzburg) Does intraoperative manometry improve results of operations for achalasia? R. Tutuian (Zurich)  Tuesday, September 5, 4:45 - 7:45 p.m.Jean-Paul Galmiche (Nantes) Opportunities and benefits of extended acid suppression Introduction Jean-Paul Galmiche (Nantes) The in-vitro and in-vivo mechanisms of extended acid suppression George Sachs (Los Angeles) Level and duration of acid suppression: what are the therapeutic goals in GORD and PUD? Donald O. Castell (Charleston) Management of Helicobacter pylori infection and NSAID-gastropathy: potential benefits of extended acid suppression Carmelo Scarpignato (Parma) Prevention and treatment of upper GI bleeding: Unmet clinical needs Chris Hawkey (Nottingham) Conclusions |
